Daniel H. Galmarini, Chief Technology Officer/Director, Physics and Engineering, 21st Century Oncology, provides an overview of adaptive radiotherapy.
Daniel H. Galmarini
Advertisement
Articles by Daniel H. Galmarini
Advertisement
Latest Updated Articles
Daniel H. Galmarini Provides an Overview of Adaptive RadiotherapySeptember 19th 2014
Advertisement
Advertisement
Trending on OncLive
1
Perioperative Enfortumab Vedotin Plus Pembrolizumab Improves ctDNA Clearance in Cisplatin-Eligible MIBC
2
Pembrolizumab Plus Chemo Misses EFS End Point in Cisplatin-Eligible MIBC
3
Sacituzumab Govitecan Triplet Elicits Durable Responses in Treatment-Naive Metastatic Urothelial Cancer
4
Atirmociclib Plus Fulvestrant Improves PFS in HR+/HER2– Advanced Breast Cancer
5